NLRP3 and chronic kidney disease: For instance, during the early phase of AKI, moderate NLRP3 activation may exert protective immune surveillance functions by facilitating the clearance of necrotic cellular debris; conversely, in CKD, persistent NLRP3 activation drives irreversible fibrosis and functional decline.